SpringWorks Targets Rare Tumors, But Myeloma Is The Mother Lode

 
• By Alaric DeArment
While SpringWorks is initially pursuing desmoid tumors, multiple myeloma represents a much bigger market • Source: Shutterstock

More from Anticancer

More from Therapeutic Category